Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first‐line therapies

Abstract

Compared to the broad group of infants with ES, children with ES in the setting of CDD often experience longer lead time to treatment and respond poorly to standard treatments. Development of alternative treatments for ES in CDD is needed.